ArticleBMC cancer2026

Combining fruquintinib with TAS-102 as a promising strategy: antitumor activity in preclinical colorectal and gastric cancer xenograft models.

Takahito Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.